Funders › MN › Rosenau Family Research Foundation › 2024
Grants paid by Rosenau Family Research Foundation, tax year 2024
EIN 26-3070514 · Muskego, MN · Form 990-PF, Part XV · NTEE T20
In tax year 2024, Rosenau Family Research Foundation (EIN 26-3070514) reported 14 grants paid totaling $1,581,155. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Nationwide Children's Hospital Columbus, OH | C | $250,000 | approved, future | Evaluation of In Utero Gene Therapy in Canine KD | 202502809349101005 |
| 2024 | University of Pittsburgh Pittsburgh, PA | U | $250,000 | approved, future | Disclosure of Newborn Screening Results for KD in Pennsylvania | 202502809349101005 |
| 2024 | Duke University Durham, NC | C | $250,000 | paid | Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD | 202502809349101005 |
| 2024 | UW Department of Pediatrics Madison, WI | U | $250,000 | approved, future | Enriching CF Newborn Screening Outcomes Through a Precision Personalized Medicine Strategy | 202502809349101005 |
| 2024 | University of Minnesota Minneapolis, MN | U | $235,000 | approved, future | GenoKrabbe: A Comprehensive Genotype-Phenotype Database for KD | 202502809349101005 |
| 2024 | University of Connecticut Health Ce Farmington, CT | U | $175,049 | paid | Evaluation of Immunomodulatory Therapy for the Treatment of KD | 202502809349101005 |
| 2024 | Biomedical Research Institute of Nj Cedar Knools, NJ | C | $149,154 | paid | Psychosine Profiling and Evaluation as a Therapeutic for KD | 202502809349101005 |
| 2024 | University of Minnesota Minneapolis, MN | U | $125,000 | paid | GenoKrabbe: A Comprehensive Genotype-Phenotype Database for KD | 202502809349101005 |
| 2024 | University of Illinois Chicago, IL | U | $125,000 | approved, future | A Maladaptive Pathway Involved In Early Pathogenesis of KD | 202502809349101005 |
| 2024 | University of Illinois Chicago, IL | U | $125,000 | paid | A Maladaptive Pathway Involved In Early Pathogenesis of KD | 202502809349101005 |
| 2024 | University of Buffalo Amherst, NY | D | $125,000 | approved, future | Modulating Oligodendroglial NFkB as a Therapeutic Strategy for KD | 202502809349101005 |
| 2024 | University of Pittsburgh Pittsburgh, PA | U | $125,000 | paid | Disclosure of Newborn Screening Results for KD in Pennsylvania | 202502809349101005 |
| 2024 | Nationwide Children's Hospital Columbus, OH | C | $125,000 | paid | Evaluation of In Utero Gene Therapy in Canine KD | 202502809349101005 |
| 2024 | University of Buffalo Amherst, NY | D | $125,000 | paid | Modulating Oligodendroglial NFkB as a Therapeutic Strategy for KD | 202502809349101005 |
| 2024 | Duke University Durham, NC | C | $125,000 | approved, future | Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD | 202502809349101005 |
| 2024 | University of Illinois Chicago, IL | U | $85,000 | approved, future | Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function | 202502809349101005 |
| 2024 | University of Illinois Chicago, IL | U | $85,000 | paid | Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function | 202502809349101005 |
| 2024 | University of Pennsylvania Philadelphia, PA | U | $60,000 | paid | Elucidating the Mechanisms Underlying Macrophage Dysfunction in KD | 202502809349101005 |
| 2024 | University of Illinois Chicago, IL | U | $60,000 | paid | Effects of Motor Learning on Efficacy and Safety of AAV-Gene Therapy in KD | 202502809349101005 |
| 2024 | University of Illinois Chicago, IL | U | $60,000 | paid | Dysfunction of Brain Synapsis in KD | 202502809349101005 |
| 2024 | University of Kansas Kansas City, KS | U | $59,593 | paid | Improving Developmental Outcomes in Mouse Models of KD | 202502809349101005 |
| 2024 | Mayo Clinic Rochester, MN | U | $57,359 | paid | Elucidating the Metabolic Signature of KD Plasma, Dried Blood Spots, and Cerebrospinal Fluid Using Flux Analysis | 202502809349101005 |
| 2024 | Mayo Clinic Rochester, MN | U | $55,359 | approved, future | Elucidating the Metabolic Signature of KD Plasma, Dried Blood Spots, and Cerebrospinal Fluid Using Flux Analysis | 202502809349101005 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.